Freya Biosciences ApS: Financial statements 2025
CVR: 41257547
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Freya Biosciences ApS (CVR 41257547) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -14,130,000 and a net result of DKK -92,714,000 compared with DKK -85,434,294 the year before. Equity in the 2025 report amounted to DKK 72,025,000. The solvency ratio was 87.4%. The company had 23 employees in the financial year.
- Gross Profit
- DKK -14,130,000
- Profit/Loss
- DKK -92,714,000
- Equity
- DKK 72,025,000
- Total Assets
- DKK 82,387,000
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -14.1 mio. | -92.7 mio. | 72 mio. | 23 |
| 2024 | - | -6.7 mio. | -85.4 mio. | 130.1 mio. | 14 |
| 2023 | - | -5.4 mio. | -81.1 mio. | 75 mio. | 14 |
| 2022 | - | -16.6 mio. | -32.2 mio. | -3.7 mio. | - |
| 2021 | 0 | -5.5 mio. | -20.4 mio. | 28.4 mio. | - |
Official annual report
How creditworthy is Freya Biosciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 3, 2025, is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
Freya Biosciences ApS has published its annual report for 2024. Gross profit came to DKK -6,657,479, and the net result was DKK -85,434,294.
About Freya Biosciences ApS
Freya Biosciences ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. The company has 18 employees (2026). In 2025, the company reported a gross profit of DKK -14,130,000 and a net result of DKK -92,714,000 compared with DKK -85,434,294 the year before. Equity in the 2025 report amounted to DKK 72,025,000.